Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kiverdi is a private industrial biotechnology company developing NASA-inspired carbon transformation technology that uses hydrogenotrophic microbes to convert carbon dioxide and other simple gaseous inputs into proteins, oils, nutrients, and other bio-based materials. The company positions itself as a platform business for circular supply chains rather than a therapeutic drug developer. Its commercial solution areas include sustainable food and feed ingredients, soil nutrient products, plastics-related circularity, and custom carbon-to-product systems for consumer and industrial partners. Kiverdi has also incubated Air Protein as a subsidiary focused on food made from air-derived inputs. Overall, Kiverdi operates at the intersection of synthetic biology, climate technology, and sustainable manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kiverdi.